- Home
- NEUP vs IMCC Comparison
NEUP vs IMCC Comparison
Compare NEUP & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- IMCC
- Stock Information
- Founded
- NEUP 1996
- IMCC 1980
- Country
- NEUP United States
- IMCC Israel
- Employees
- NEUP N/A
- IMCC N/A
- Industry
- NEUP
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- NEUP
- IMCC Health Care
- Exchange
- NEUP Nasdaq
- IMCC Nasdaq
- Market Cap
- NEUP 10.3M
- IMCC 10.4M
- IPO Year
- NEUP N/A
- IMCC N/A
- Fundamental
- Price
- NEUP $4.36
- IMCC $1.75
- Analyst Decision
- NEUP Strong Buy
- IMCC
- Analyst Count
- NEUP 2
- IMCC 0
- Target Price
- NEUP $28.00
- IMCC N/A
- AVG Volume (30 Days)
- NEUP 229.1K
- IMCC 134.9K
- Earning Date
- NEUP 11-14-2025
- IMCC 11-13-2025
- Dividend Yield
- NEUP N/A
- IMCC N/A
- EPS Growth
- NEUP N/A
- IMCC N/A
- EPS
- NEUP N/A
- IMCC N/A
- Revenue
- NEUP $15,649,448.00
- IMCC $37,606,703.00
- Revenue This Year
- NEUP N/A
- IMCC $47.12
- Revenue Next Year
- NEUP N/A
- IMCC $12.83
- P/E Ratio
- NEUP N/A
- IMCC N/A
- Revenue Growth
- NEUP N/A
- IMCC 1.92
- 52 Week Low
- NEUP $2.90
- IMCC $0.93
- 52 Week High
- NEUP $21.40
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- NEUP 36.38
- IMCC 59.16
- Support Level
- NEUP $4.13
- IMCC $0.93
- Resistance Level
- NEUP $4.59
- IMCC $1.49
- Average True Range (ATR)
- NEUP 0.38
- IMCC 0.19
- MACD
- NEUP 0.30
- IMCC 0.06
- Stochastic Oscillator
- NEUP 22.94
- IMCC 87.89
About NEUP Neuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.